1. Polymers of orosomucoid were produced in two molecular shapes, filamentous ('chain') and spherical ('ball') , by heating the sodium salt of the monomer in either water or high concentrations of sodium chloride. An 'intermediate' state containing both shapes in various proportions was found in preparations obtained by polymerizing orosomucoid in intermediate concentrations of sodium chloride. 2. The filamentous form ofpolymer was found to inhibit strongly the haemagglutination of some ('sensitive') strains but not of other ('insensitive') strains of influenza virus; the 'intermediate' form feebly inhibited haemagglutination by 'sensitive' strains. 3. The filamentous form agglutinated both 'sensitive' and 'insensitive' strains of virus; the other forms of polymer did not. It also inhibited multiplication of both 'sensitive' and 'insensitive' strains when inoculated into embryonated and de-embryonated eggs. 4. The 'intermediate'and spherical forms ofthe polymer had no effect on the virus multiplication. 5. Polymers of orosomucoid from which neuraminic acid had been split off had no detectable effect on influenza viruses.
It has long been known that many mucoproteins of high molecular weight inhibit haemagglutination and infectivity by myxoviruses. Orosomucoid, a mucoprotein of molecular weight 41000, has little or no such activity. But when polymerized it has been found to be a powerful inhibitor of haemagglutination by some strains of influenza virus (and other myxoviruses) but not others (Whitehead, 1965; Whitehead, Flewett, Foster & Sammons, 1965) .
The conditions for polymerization and the kinds of polymer produced have been further investigated, and the results are described in the preceding paper (Spragg, Halsall, Flewett & Barclay, 1969) . The present paper describes various biological activities of polymerized orosomucoid: the inhibition of haemagglutination by some strains, but not others, of influenza virus and other myxoviruses, the inhibition of multiplication of some of these viruses, and the agglutination of viruses.
The activities of 'chain' and of 'ball' forms of polymer and the activity of polymerized orosomucoid protein without associated N-acetylneuraminic acid are described and discussed below.
METHODS
Preparation of oro8omucoid and polymer8. Orosomucoid was prepared as previously described (Easton, Hardwicke & Whitehead, 1962; Barker & Whitehead, 1963; Spragg et al. 12 1969) . Polymers were made by heating 0.5% solutions of orosomucoid in sealed test tubes in a water bath, and examined in the electron microscope as described in the preceding paper (Spragg et al. 1969 ).
Influenza-virus 8train8 u8ed. Influenza-virus strains A/PR8, A/DSP, A/Persian Gulf Mill Hill 2408 2/55, Al/England/55, an un-numbered A2/England/65, an A2/England/66, A/fowl plague Dutch strain, B/Lee, B/Taiwan 4/62 WIC 32367 LI, and the 1233 strain of influenza C were propagated by allantoic (or for the influenza C, amniotic) inoculation of 10-day-old embryonated eggs.
Indicator suspensions of the A/PR8 and A/DSP strains of influenza virus for use in haemagglutination-inhibition tests were prepared by diluting infected allantoic fluid 1: 5 in borate-citrate buffer, pH (Clarke & Lubs, 1917) , and heating at 56°in a water bath for 30min.
Haemagglutination-inhibition te8t8. Twofold serial dilu. tions of the polymer under investigation were made in 0-25 ml. ofveronal-buffered saline, pH 7-2, and eight minimal haemagglutinating doses of indicator virus in a volume of 0-25ml. were added to each dilution. After the samples had been kept for 30min. at room temperature, 0-25ml. of a 1% (v/v) (Choppin & Stoeckenius, 1964) . In a further experiment the concentrated virus was disrupted by exposure to sodium deoxycholate for 10min. at room temperature to produce much smaller sub-units than those produced by ether disruption (Laver, 1963) . The appearances of the haemagglutinating components prepared by ether or deoxycholate treatment and the absence of intact virus particles were verified by electron microscopy of negative-stained preparations. The resulting suspension was purified by adsorption on and elution from fowl erythrocytes, and was converted into the indicator state by methods similar to those used for preparing whole indicator virus.
Purified virus, concentrated 20-fold by centrifugation and resuspension in water, was used in agglutinationinhibition tests. The virus suspension was disaggregated by ultrasonic vibration for 3min. or longer, until the particles in samples examined by dark-ground microscopy were seen to be evenly distributed. Volumes of polymer, of pH4-5, diluted 1:10, 1:50, 1:100, 1:500 and 1:1000 in sterile water and mixed with equal volumes of concentrated virus, were left for 2hr. at room temperature and examined macroscopically. Agglutination was verified by dark-ground microscopy.
Inhibition of virus growth. 'Low-, medium-and high-salt' polymers (Spragg et at. 1969) , sterilized by passage through a membrane filter, were inoculated allantoically into 10-dayold fertile eggs together with 103 egg-infectivity doses of virus in 0-1 ml. of Eagle's solution, pH 7-2, and the eggs were incubated for 42hr. at 350 before being harvested. After incubation, allantoic fluids were titrated for the content of haemagglutinin and infective virus.
De-embryonated eggs were prepared by removing the contents of 10-12-day-old embryonated eggs, except for the chorioallantoic membrane; lOml. of Eagle's solution, lml. of 'low-salt' polymer solution together with an inoculum of 103 egg-infective doses of virus were introduced, and the shell was sealed; in some experiments polymer was introduced 1 hr. or 3 hr. before the virus inoculum. The eggs were rotated at 350 for 42-46hr. before being tested for haemagglutinin and infectivity as before.
RESULTS
Inhibition of haemaggltutination. Electron microscopy revealed that the shape of polymer molecules of orosomucoid differed according to the salt concentration in which they were polymerized. Preparations made in water contained filamentous forms only (Plate la), and those made in 6% (w/v) sodium chloride contained predominantly spherical forms with a small proportion of short filaments (Plate 2c). Filamentous ('chain') and spherical ('ball') (Table 4) .
Thus maximum inhibitory activity was found in Inhibition of virus multiplication. Preliminary tests with 10-day-old embryonated eggs established that: (1) allantoic inoculation of 1 ml. of 'low-salt' polymer, sterilized by filtration, was harmless to the embryo; (2) 1 ml. of 'low-salt' polymer inoculated almost simultaneously with 103 egg-infective doses of the influenza-virus strain A/PR8 into the allantoic cavity inhibited viral growth; (3) smaller doses of polymer did not prevent viral growth; (4) infectivity was not inhibited if virus was inoculated 1 hr. either before or after the polymer.
A sample (lml.) of 'low-, medium-or high-salt' polymer solution (0-5%, polymer) was therefore used as a standard inoculum to determine the effect on the multiplication of 103 egg-infective doses of virus strains A/PR8 and A/DSP. The results are given in Table 6 . The 'low-salt' polymer completely inhibited multiplication of the influenza-virus strain A/PR8 in two tests; both haemagglutinin and infectivity were absent from the allantoic fluid of inoculated eggs after 48hr. incubation. In the other two tests, polymerized orosomucoid suppressed viral multiplication and the allantoic fluid lacked haemagglutinin but was infective; this was also the case in three tests with strain A/DSP (Table 6) .
Introduction of 'medium-salt' and 'high-salt' polymer had no effect on the growth of virus in embryonated eggs. Similar results were obtained when the experiments were repeated in the chorioallantoic membranes of de-embryonated eggs. Both 'sensitive' and 'insensitive' strains were inhibited. In the four tests carried out the membranes failed to produce haemagglutinin, but 0-1 ml. of the culture was infective to embryonated eggs. In most experiments polymerized orosomucoid and virus were introduced to the de-embryonated eggs at approximately the same time. But, in contrast with the findings with embryonated eggs, if polymerized orosomucoid was added either 1 hr. or 3hr. before the virus, the results were the same as when the orosomucoid and virus were introduced together. After 48hr. incubation, the de-embryonated eggs failed to produce haemagglutinin but contained infective virus.
DISCUSSION

Inhibition of haemagglutination. It has been
shown that polymers of orosomucoid actively inhibit haemagglutination by certain strains of influenza virus .
In the range of polymers investigated in the present paper, the 'low-salt' ('chain') polymer of filamentous form was the most efficient inhibitor of viral haemagglutination and multiplication. It was also the only form of polymer to agglutinate virus suspensions. However, it failed to inhibit haemagglutination by either whole or fractionated virus of certain strains.
Sensitive and resistant strains can be found among influenza viruses that are antigenically very similar, e.g. A2 strains. We can only speculate about the differences between the strains that determine whether they are sensitive or resistant to poly-EXPLANATION OF PLATES 1-4 (a) Orosomucoid polymerized by heating a solution in water. Filamentous ('chain') molecules negatively stained with uranyl formate can be seen. (b) Both filamentous ('chain') and spherical ('ball') forms of polymer can be seen. The stain was uranyl formate. (c) Spherical molecules of orosomucoid polymerized in 6% NaCl. The stain was uranyl formate. (d) Influenza virus completely covered by excess of filamentous orosomucoid polymer. The normal surface structure of the virus is completely obscured. The stain was phosphotungstate. (e) and (f) Influenza virus mixed with filamentous polymerized orosomucoid. Filamentous molecules can be seen overlying the surface projections (spikes) of the virus and linking adjacent virus particles (at the arrows). The stain was phosphotungstate. (g) A chain of influenza particles connected together by filamentous orosomucoid. The stain was phosphotungstate. The dimension marks indicate 0-1 ,u (lOOnm.).
